All In MedTech

Device Trial Radar · NCT06889298

EXOMIND (BTL-699) for the Reduction of Food Cravings

Safety and Efficacy of the BTL-699 Device for Temporary Reduction of Food Cravings

Last checked: Nov 20, 2026Latest source record: Sep 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

29

Actual

Start

Feb 9, 2023

Primary completion

Jun 20, 2023

Study completion Jun 20, 2023

Sponsor

Lead sponsor
BTL Industries Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Mar 21, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate if the treatment with BTL-699 device is able to temporarily reduce food cravings in adults above the age of 22 years. The main question it aims to answer is: Does the treatment with BTL-699 device provide a temporary reduction of food cravings? Participants will be asked to: * Undergo 4 to 6 treatments * Undergo weight measurements * Complete the Food Cravings Questionnaire-Trait * Complete the Therapy Comfort Questionnaire * Complete the Satisfaction Questionnaire

Conditions

  • Food Cravings

Interventions

  • Treatment with BTL-699Device

    Four to six transcranial magnetic stimulation treatments with the BTL-699 device will be delivered over the left dorsolateral prefrontal cortex, spaced 2 to 3 days apart. The intensity will be adjusted according to the subject's feedback, up to 100% of the individual's motor threshold.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of Change in Food CravingsTime frame: 15 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Institute for Mental Health

    Klecany, Czechia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.